Related Articles
Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues
Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review)
Application of organoids in precision immunotherapy of lung cancer (Review)
Establishment of patient-derived cancer xenografts in immunodeficient NOG mice
Xenografts derived from patients with head and neck cancer recapitulate patient tumour properties